Jenny Tam

Donald Ingber, a pioneer in organ-on-a-chip technology, and Jenny Tam, an innovative researcher in synthetic biology, discuss the future of animal testing in biomedical research. They delve into new alternatives like organoids and AI-driven methods that could render traditional models obsolete. The conversation highlights the FDA Modernization Act 2.0, which aims to eliminate animal testing requirements, and explores ethical implications and financial considerations of adopting advanced drug testing technologies. Their insights shed light on the potential transformation of the pharmaceutical landscape.